Tinidazole
- Generic Name
- Tinidazole
- Brand Names
- Tindamax
- Drug Type
- Small Molecule
- Chemical Formula
- C8H13N3O4S
- CAS Number
- 19387-91-8
- Unique Ingredient Identifier
- 033KF7V46H
- Background
A nitroimidazole antitrichomonal agent effective against Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia infections.
- Indication
For the treatment of trichomoniasis caused by T. vaginalis in both female and male patients. Also for the treatment of giardiasis caused by G. duodenalis in both adults and pediatric patients older than three years of age and for the treatment of intestinal amebiasis and amebic liver abscess caused by E. histolytica in both adults and pediatric patients olde...
- Associated Conditions
- Amebiasis, Bacterial Vaginosis (BV), Giardiasis, Mixed Vaginal Infections, Nongonococcal urethritis, Sexually Transmitted Disease (STD), Trichomonas Vaginalis Infection, Trichomonas Vaginitis, Vaginal Candidiasis
- Associated Therapies
- -
Treatment of Bacterial Vaginosis With Oral Tinidazole
- Conditions
- First Posted Date
- 2005-09-29
- Last Posted Date
- 2017-03-22
- Lead Sponsor
- Mission Pharmacal
- Target Recruit Count
- 200
- Registration Number
- NCT00229216
- Locations
- 🇺🇸
Duke University School of Medicine, Durham, North Carolina, United States
Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach
- Conditions
- First Posted Date
- 2004-03-12
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- Lymphoma Trials Office
- Target Recruit Count
- 200
- Registration Number
- NCT00003617
- Locations
- 🇬🇧
Clatterbridge Centre for Oncology NHS Trust, Merseyside, England, United Kingdom
🇬🇧Leeds Teaching Hospital Trust, Leeds, England, United Kingdom
🇬🇧Essex County Hospital, Colchester, England, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.